Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11032 results:
[ Συντάκτης(Asc)] Τίτλος Τύπος Έτος
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
I
Imprialos, K., Doumas M., Tokamani M., Sandaltzopoulos R., & Athyros V. G. (2017).  Editorial: The microRNA 221/222 Cluster: Inaugurating a New Era in Cardiovascular Disease and Cancer?. Curr Vasc Pharmacol. 15(1), 47-50.
Imprialos, K. P., Sarafidis P. A., & Karagiannis A. I. (2015).  Sodium-glucose cotransporter-2 inhibitors and blood pressure decrease: a valuable effect of a novel antidiabetic class?. J Hypertens. 33(11), 2185-97.
Imprialos, K. P., Stavropoulos K., Doumas M., Karagiannis A., & Athyros V. G. (2017).  The effect of SGLT2 inhibitors on cardiovascular events and renal function.. Expert Rev Clin Pharmacol. 10(11), 1251-1261.
Imprialos, K., Boutari C., & Doumas M. (2016).  Discontinuation of Antihypertensive Treatment in Elderly Patients and Cognitive Function.. JAMA Intern Med. 176(3), 409.
Imprialos, K., Faselis C., Boutari C., Stavropoulos K., Athyros V., Karagiannis A., et al. (2017).  SGLT-2 Inhibitors and Cardiovascular Risk in Diabetes Mellitus: A Comprehensive and Critical Review of the Literature.. Curr Pharm Des. 23(10), 1510-1521.
Imprialos, K. P., Stavropoulos K., Stavropoulos N., Patoulias D., Petidis K., Grassos C., et al. (2018).  Sodium-glucose Cotransporter 2 Inhibitors: Impact on Body Weight and Blood Pressure Compared with other Antidiabetic Drugs.. Cardiovasc Hematol Disord Drug Targets. 18(2), 104-113.
Imprialos, K. P., Boutari C., Stavropoulos K., Sampani E., & Karagiannis A. I. (2016).  Renin-Angiotensin System Inhibitors: Do They Have the Same Impact at All Ages?. J Clin Hypertens (Greenwich). 18(8), 828.
Imprialos, K. P., Stavropoulos K., & Doumas M. (2017).  Liraglutide and Renal Outcomes in Type 2 Diabetes.. N Engl J Med. 377(22), 2196.
Imprialos, K. P., Boutari C., Stavropoulos K., Doumas M., Athyros V. G., & Karagiannis A. I. (2016).  Current challenges in antihypertensive treatment in the elderly.. Pol Arch Med Wewn. 126(7-8), 540-51.
Imprialos, K., Boutari C., Stavropoulos K., Doumas M., & Karagiannis A. I. (2016).  Depression in hypertensive patients: the role of comorbidities.. J Hypertens. 34(7), 1441.
Imprialos, K. P., Stavropoulos K., & Doumas M. (2017).  Once-Weekly Exenatide and Cardiovascular Outcomes in Type 2 Diabetes.. N Engl J Med. 377(25), 2502.
Imprialos, K. P., Boutari C., Stavropoulos K., Doumas M., & Karagiannis A. I. (2017).  Stroke paradox with SGLT-2 inhibitors: a play of chance or a viscosity-mediated reality?. J Neurol Neurosurg Psychiatry. 88(3), 249-253.
Imprialos, K. P., Stavropoulos K., & Doumas M. (2018).  Sodium-glucose Co-transporters 2 Inhibitors: The Miraculous Route from Hypoglycemic to Cardiovascular Drugs.. Cardiovasc Hematol Disord Drug Targets. 18(2), 83-85.
Imam, M. H., Gossard A. A., Sinakos E., & Lindor K. D. (2012).  Pathogenesis and management of pruritus in cholestatic liver disease.. J Gastroenterol Hepatol. 27(7), 1150-8.
Imam, M. H., Sinakos E., Gossard A. A., Kowdley K. V., Luketic V. A. C., M Harrison E., et al. (2011).  High-dose ursodeoxycholic acid increases risk of adverse outcomes in patients with early stage primary sclerosing cholangitis.. Aliment Pharmacol Ther. 34(10), 1185-92.
Imam, M. H., Silveira M. G., Sinakos E., Gossard A. A., Jorgensen R., Keach J., et al. (2012).  Long-term outcomes of patients with primary biliary cirrhosis and hepatocellular carcinoma.. Clin Gastroenterol Hepatol. 10(2), 182-5.
Iliou, K., Paraskevas G., Kanavaros P., Gekas C., Barbouti A., & Kitsoulis P. (2015).  Relationship between pedographic analysis and the Manchester scale in hallux valgus.. Acta Orthop Traumatol Turc. 49(1), 75-9.
Iliopoulou, E. G., Kountourakis P., Karamouzis M. V., Doufexis D., Ardavanis A., Baxevanis C. N., et al. (2010).  A phase I trial of adoptive transfer of allogeneic natural killer cells in patients with advanced non-small cell lung cancer.. Cancer Immunol Immunother. 59(12), 1781-9.
Iliopoulos, E., Galanis N., Zafeiridis A., Iosifidis M., Papadopoulos P., Potoupnis M., et al. (2017).  Anatomic single-bundle anterior cruciate ligament reconstruction improves walking economy: hamstrings tendon versus patellar tendon grafts.. Knee Surg Sports Traumatol Arthrosc. 25(10), 3155-3162.
Iliopoulos, E., Galanis N., Iosifidis M., Zafeiridis A., Papadopoulos P., Potoupnis M., et al. (2015).  Anterior cruciate ligament deficiency reduces walking economy in "copers" and "non-copers".. Knee Surg Sports Traumatol Arthrosc.
Iliodromiti, Z., Zygouris D., Sifakis S., Pappa K. I., Tsikouras P., Salakos N., et al. (2013).  Acute lung injury in preterm fetuses and neonates: mechanisms and molecular pathways.. J Matern Fetal Neonatal Med. 26(17), 1696-704.
Ilias, I., Karagiorga V., Paraskevas G., Bougea A., Bourbouli M., Pappa A., et al. (2015).  Thyroid Autoantibodies in the Cerebrospinal Fluid of Subjects with and without Thyroid Disease: Implications for Hashimoto's Encephalopathy.. J Thyroid Res. 2015, 819072.
Iliadou, V., Kaprinis S., Kandylis D., & St Kaprinis G. (2010).  Hemispheric laterality assessment with dichotic digits testing in dyslexia and auditory processing disorder.. Int J Audiol. 49(3), 247-52.
Iliadou, V. Vivian, Sirimanna T., & Bamiou D-E. (2016).  CAPD Is Classified in ICD-10 as H93.25 and Hearing Evaluation-Not Screening-Should Be Implemented in Children With Verified Communication and/or Listening Deficits.. Am J Audiol. 25(4), 368-370.
Iliadou, V. Vivian, & Eleftheriadis N. (2018).  Response to the Letter from Dr. Vermiglio Regarding Iliadou and Eleftheriadis (2017): CAPD is Classified in ICD-10 as H93.25.. J Am Acad Audiol. 29(3), 264-265.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές